China’s Alwin Capital has closed an oversubscribed dual-currency fund at over 2 billion yuan ($281.1 million) to raise its stakes in the life sciences industry.
The new fund secured capital commitments from a wide range of limited partners including large-scale funds of funds (FOFs), government-guided funds, healthcare corporates, insurers, commercial banks, and other financial institutions, Alwin Capital announced in a statement.
